OPRX
OptimizeRx Corp
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$8.74
+2.82%Year over year
Reported trailing growth
- Revenue
- -5.8%
- EBITDA
- +1413.8%
- EBIT
- +393.1%
- EPS
- +145.0%
- Free cash flow
- +80.6%
- Operating cash flow
- +77.0%
Forward estimates
Based on analyst estimates
- Revenue
- +3.9%
- EBITDA
- +80.2%
- EPS
- +288.3%
Three-year CAGR
- Revenue
- +20.6%
- EBITDA
- +286.3%
- EBIT
- +188.0%
- Net income
- +125.5%
- EPS
- +125.5%
- Free cash flow
- +21.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026